Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Other financing activities (2017 - 2022)

Cue Biopharma (CUE) has disclosed Other financing activities for 3 consecutive years, with -$1000.0 as the latest value for Q4 2022.

  • Quarterly Other financing activities changed N/A to -$1000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$1000.0 through Sep 2023, down 100.7% year-over-year, with the annual reading at $141000.0 for FY2022, N/A changed from the prior year.
  • Other financing activities hit -$1000.0 in Q4 2022 for Cue Biopharma, down from $142000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $509000.0 in Q2 2018 to a low of -$1.1 million in Q1 2018.